Ftse Mib
36.123,00
-0,26%
DAX
21.394,84
-0,05%
S&P 500
5.994,57
-0,76%
NASDAQ
19.391,96
-1,20%
Bitcoin
98.689,30
-2,69%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ REGENXBIO Inc (RGNX) REGENXBIO Inc (RGNX) Notizie

REGENXBIO Inc

RGNX
7,82
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:22:27
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/1/202513:05PRNUSREGENXBIO Announces Presentations of RGX-121 at the 21st..
14/1/202513:08EDGAR2Form 8-K - Current report
14/1/202511:00PRNUSREGENXBIO and Nippon Shinyaku Announce Exclusive Partnership..
13/1/202514:31PRNUSAbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314..
09/1/202500:45EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
06/1/202522:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202422:09EDGAR2Form 144 - Report of proposed sale of securities
09/12/202423:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/12/202422:45EDGAR2Form 8-K - Current report
07/12/202400:29PRNUSApollo Global Management and Workday Set to Join S&P 500;..
14/11/202413:05PRNUSREGENXBIO to Host Webcast Discussing Pivotal Program and..
06/11/202422:10EDGAR2Form 8-K - Current report
06/11/202422:05PRNUSREGENXBIO Reports Third Quarter 2024 Financial Results and..
04/11/202413:05PRNUSREGENXBIO to Participate in Upcoming Investor Conferences
30/10/202412:05PRNUSREGENXBIO to Host Conference Call on November 6 to Discuss..
21/10/202413:05PRNUSREGENXBIO Presents Positive Data from the Phase II Study of..
18/10/202413:05PRNUSREGENXBIO Announces Presentations at the American Academy of..
23/9/202422:05PRNUSREGENXBIO to Participate in Chardan's 8th Annual Genetic..
18/9/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202423:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
17/9/202423:00EDGAR2Form 8-K - Current report
17/9/202413:05PRNUSREGENXBIO Appoints Mitchell Chan as Chief Financial Officer
03/9/202414:04PRNUSREGENXBIO Announces Positive Data from Pivotal Dose Level of..
29/8/202422:05PRNUSREGENXBIO to Participate in Upcoming Investor Conferences
27/8/202413:05PRNUSREGENXBIO Announces Presentation at the Society for the..
12/8/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202413:05PRNUSREGENXBIO to Participate in the H.C. Wainwright 4th Annual..
06/8/202400:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202422:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202422:10EDGAR2Form 8-K - Current report
01/8/202422:05PRNUSREGENXBIO Reports Second Quarter 2024 Financial Results and..
01/8/202413:03PRNUSREGENXBIO ANNOUNCES NEW POSITIVE DATA FROM AFFINITY..
26/7/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202413:05PRNUSREGENXBIO to Host Conference Call on August 1 to Discuss..
18/7/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/6/202413:05PRNUSREGENXBIO Announces Expansion of AFFINITY DUCHENNE® Trial to..
18/6/202413:05PRNUSREGENXBIO Announces Successful Pre-BLA Meeting with FDA to..
12/6/202413:05PRNUSREGENXBIO Announces Leadership Transition
05/6/202413:05PRNUSREGENXBIO to Participate in the Goldman Sachs 45th Annual..
04/6/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:35EDGAR2Form 8-K - Current report
16/5/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202422:22EDGAR2Form 144 - Report of proposed sale of securities
10/5/202413:05PRNUSREGENXBIO to Participate in Upcoming Investor Conferences
Apertura: Min: Max:
Chiusura: 7,82

La tua Cronologia

NASDAQ
RGNX
REGENXBIO
NASDAQ
FCKZX
Beutel Goodman Short Ter...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci